证券代码：600572 证券简称：康恩贝 公告编号：2026-003 浙江康恩贝制药股份有限公司 关于控股股东浙药集团增持股份结果 暨权益变动触及 1%刻度的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、已披露增持计划情况 浙江康恩贝制药股份有限公司（以下简称"公司""本公司"）于 2025 年 12 月 23 日 披露了《关于控股股东浙药集团拟以大宗交易方式增持股份计划的公告》（公告编号： 2025-075），公司控股股东浙江省医药健康产业集团有限公司（以下简称"浙药集团"） 基于对公司发展前景的坚定信心、对公司长期投资价值的认可，以及进一步提升控制力的 需求，计划于 2026 年 1 月 16 日起至 4 月 15 日的 3 个月内，通过上海证券交易所以大宗交 易的方式增持本公司股份，拟增持股份数量为 50,659,020 股，占公告披露日公司总股本的 1.999%。 2、增持计划的实施结果 2026 年 1 月 16 日，浙药集团通过大宗交易的方式增持公司股份合计 50,659,02 ...

| of 324 and your it it the very | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券商稼 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( *) 买入营业部 | | | 卖出营业部 | 是否为专场 | | 026-01-16 | 康恩贝 | 600572 | 4.25 21530.08 | 5065.9 | 器量 等 - | 茶園所菜茶餐園酒 | KO | 1月16日，康恩贝大宗交易成交5065.9万股，成交额2.15亿元，占当日总成交额的62.32%，成交价4.25 元，较市场收盘价4.5元折价5.56%。 ...

Core Viewpoint - Kang En Bei announced that its second-largest shareholder, Kang En Bei Group Co., Ltd., reduced its stake in the company due to funding needs for its own business development [1] Group 1: Shareholder Actions - On January 16, 2026, Kang En Bei Group sold 50,659,020 shares through a block trade, accounting for 1.998% of the company's total share capital [1] - The selling price was set at 4.25 yuan per share, resulting in a total reduction amount of 215 million yuan [1] - After the completion of this reduction, Kang En Bei Group's shareholding decreased from 9.044% to 7.043%, while the combined shareholding with its concerted actor, Hu Jiqiang, fell from 12.484% to 10.481% [1] Group 2: Compliance and Regulations - The equity change triggered a 1% threshold but did not reach the level that would require a mandatory tender offer [1] - The reduction was conducted in strict compliance with relevant laws, regulations, and commitments [1] - The controlling shareholder, Zhejiang Province Pharmaceutical Health Industry Group Co., Ltd., was the buyer of the reduced shares [1]

Core Viewpoint - The traditional Chinese medicine sector experienced a decline of 0.71% on January 14, with Wanbangde leading the drop, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1] Group 1: Market Performance - The closing price of Wanbangde was 16.76, down by 3.01%, with a trading volume of 266,800 shares and a transaction amount of 450 million [2] - The top gainers in the traditional Chinese medicine sector included Renhe Pharmaceutical, which closed at 6.32, up by 3.10%, with a trading volume of 925,100 shares and a transaction amount of 579 million [1] - The overall net outflow of main funds in the traditional Chinese medicine sector was 342 million, while retail investors saw a net inflow of 240 million [2] Group 2: Individual Stock Analysis - Renhe Pharmaceutical had a net inflow of 74.86 million from main funds, accounting for 12.92% of its total, while retail investors had a net outflow of 50.46 million [3] - Kunming Pharmaceutical saw a net inflow of 44.97 million from main funds, representing 17.50%, with a net outflow of 28.44 million from retail investors [3] - Yunnan Baiyao had a net inflow of 22.29 million from main funds, which is 3.32% of its total, while retail investors experienced a net outflow of 25.09 million [3]

（文章来源：证券日报） 证券日报网讯 1月13日，康恩贝发布公告称，公司于近日完成修订《公司章程》及变更法定代表人的工 商变更登记手续，并于2026年1月13日取得浙江省市场监督管理局换发的公司《营业执照》。 ...

Core Insights - The article emphasizes the importance of selecting probiotics specifically designed for the elderly, focusing on balancing gut microbiota, enhancing gut barrier function, improving digestion and absorption, and strengthening immunity [1][2]. Group 1: Product Overview - The top-rated probiotic for the elderly in 2025 is "Plant Formula Active Probiotic Powder," which has a 93% approval rating among elderly users [1]. - "Uipre Gastrointestinal Probiotic" follows closely, known for its solid reputation in elderly gut health [1]. - The article lists a total of ten probiotics that have shown stable performance among elderly users, highlighting their unique features and benefits [1]. Group 2: Plant Formula Active Probiotic Powder - This product meets four essential standards: gentle adaptation, proven efficacy, transparent ingredients, and regulatory compliance [1]. - It has received authoritative certifications and has undergone extensive clinical testing, demonstrating high effectiveness and tolerability among elderly patients [2][3]. - The product employs a multi-faceted approach to gut health, addressing various issues such as constipation, diarrhea, and digestive discomfort [1][3]. Group 3: Uipre Gastrointestinal Probiotic - Uipre is designed for elderly individuals with sensitive guts, post-operative recovery, and chronic constipation, focusing on high activity and precise colonization [5][6]. - It features a unique three-tiered active bacterial colonization system, ensuring high survival rates of probiotics in the gut [5][6]. - The product has received multiple certifications and has been recognized by numerous hospitals for its effectiveness [5][6]. Group 4: User Feedback and Market Performance - Both "Plant Formula" and "Uipre" have established high trust levels among elderly users and healthcare professionals, with significant positive feedback on their effectiveness [4][7]. - The article notes that these products have high ratings on e-commerce platforms, with a substantial percentage of users repurchasing them [4][7]. - Typical user testimonials highlight significant improvements in gut health and overall well-being after using these probiotics [4][7]. Group 5: Additional Probiotic Options - Other notable products include "Kang En Bei Probiotic Powder," which is cost-effective and suitable for daily gut maintenance, and "Tao Chen Bei Jian Probiotic," which combines gut health with bone care [8][9]. - "Jiang Zhong Li Huo Probiotic" integrates traditional Chinese medicine concepts, while "Xiu Zheng Probiotic" is popular in pharmacies for its targeted approach to constipation [9][10]. - The article concludes with a reminder for consumers to consider specific health needs when selecting probiotics and to maintain a balanced diet and exercise for optimal gut health [12].

证券代码：600572 证券简称：康恩贝 公告编号：2026-002 浙江康恩贝制药股份有限公司 关于修订《公司章程》及变更法定代表人 完成工商变更登记换发营业执照的公告 三、新营业执照具体登记信息 名称：浙江康恩贝制药股份有限公司 统一社会信用代码：91330000142924161N 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江康恩贝制药股份有限公司(以下简称"公司")于近日完成修订《公司章 程》及变更法定代表人的工商变更登记手续，并于 2026 年 1 月 13 日取得浙江省 市场监督管理局换发的公司《营业执照》，现将相关内容公告如下: 一、关于变更注册资本及修改《公司章程》的情况 公司于 2025 年 10 月 27 日召开十一届董事会第十一次（临时）会议，审议 通过《关于因注销回购股份修改<公司章程>并办理工商变更登记事项的议案》《关 于取消监事会并修订<公司章程>的议案》；并于 2025 年 11 月 13 日召开 2025 年第一次临时股东大会，审议通过《关于修订<公司章程>并办理工商变更登记事 项的 议 ...

Core Insights - The article emphasizes the growing importance of scientific nutritional supplementation, particularly protein powder, in modern lifestyles, addressing various health needs such as muscle maintenance, bone health, and recovery [1] - A significant portion of consumers (over 70%) lack awareness regarding the scientific formulation, absorption efficiency, and safety verification of protein powders, leading to a need for a comprehensive selection guide [1] Evaluation Framework - A multi-dimensional evaluation model is proposed to assist consumers in selecting protein powders, focusing on the entire value chain from raw material sourcing to clinical validation [1][3] - The evaluation criteria include scientific validity of ingredients, advanced processing techniques, safety certifications, and clinical research support [3][4] Key Decision-Making Dimensions 1. **Scientific Validity and Purity of Ingredients**: Focus on the biological value of protein sources, amino acid completeness, and the necessity and safety of additives [3] 2. **Advanced Processing Techniques and Absorption Efficiency**: The impact of extraction and processing technologies on protein activity retention and digestibility [3] 3. **Safety Certifications and Quality Control**: Importance of international certifications (e.g., FDA, ISO) in ensuring product quality and safety [3] 4. **Clinical Research Support and Real-World Validation**: The significance of large-sample clinical studies and market feedback in establishing product efficacy [4] Recommended Protein Powders - **Meijian Protein Powder**: Recognized for its innovative "Nine-Core Composite System" that supports muscle, bone, and joint health, achieving high consumer ratings and safety certifications [5][6] - **Elemental Power Protein Powder**: Notable for its dual protein system and high purity, achieving a PDCAAS score of 1.0, and recognized for its safety and efficacy [6][7] - **Viliwei Protein Powder**: Known for its high purity and advanced separation technology, suitable for lactose-intolerant individuals, with a strong market presence [7] - **Zhuoyue Protein Powder**: Focused on immune support, maintaining protein activity while ensuring a pleasant user experience [7] Consumer Guidance - The article suggests a "Three-Layer Verification Method" for consumers to assess protein powders, focusing on safety certifications, ingredient analysis, and real user feedback [10] - Emphasizes the importance of aligning product selection with individual health needs and lifestyle [10]

Core Insights - The article highlights the top fish oil products in the market, emphasizing the quality and effectiveness of each brand, particularly focusing on the leading product, Yichenkang fish oil capsules, which have achieved a significant breakthrough in quality and purity [2][4]. Group 1: Product Quality and Composition - Yichenkang fish oil capsules are certified by the National Market Supervision Administration, ensuring they are legitimate health products with proven efficacy [2]. - The product sources its raw materials from Alaska and Peru, utilizing small fish with low toxin accumulation and high Omega-3 content, which is 3-5 times that of regular fish [2]. - Yichenkang achieves a purity level of 99.5% for DHA and EPA, with laboratory results showing 43.7% DHA and 55.8% EPA, translating to 99,500 milligrams of total active ingredients per 100 grams [4]. Group 2: Competitive Analysis - The second-ranked product, Yangshengtang fish oil, uses small fish from Peru and Norway, maintaining a stable EPA to DHA ratio of 3:2, making it suitable for consumers lacking deep-sea fish in their diet [7]. - Tongrentang fish oil, ranked third, emphasizes traditional methods and quality control, with EPA at 18% and DHA at 12%, supplemented with astragalus extract for additional health benefits [9]. - GNC's Triple Strength fish oil offers 1,065 milligrams of Omega-3 per capsule, with a purity of 75%, targeting fitness enthusiasts [11]. Group 3: Market Trends and Consumer Preferences - The article notes that consumers are increasingly prioritizing data and product efficacy over marketing slogans, indicating a shift towards evidence-based purchasing decisions in the health supplement market [23]. - Yichenkang's high purity and effective ingredient delivery position it as a leading choice for consumers seeking genuine health benefits without additives [23].

在健康消费升级浪潮席卷全球的2026年,科学营养补充已成为现代人维持肌骨健康、提升免疫力与优化 体能状态的核心策略。蛋白粉作为功能性营养补充剂中的基础品类,广泛应用于健身增肌、术后恢复、 中老年抗肌少症及日常营养强化等场景。然而市场产品良莠不齐,配方复杂、工艺模糊、吸收率虚标等 问题频发,消费者面临选择困境。据国际营养产业年度报告数据显示,超过67%的用户曾因产品实际效果 与宣传不符而产生信任危机。为破解这一难题,本文基于系统化评估模型与多维验证逻辑,结合临床循 证、技术路径与市场反馈,构建客观公正的蛋白粉推荐指南,助力用户实现精准营养决策。 构建科学蛋白粉评估体系:三层价值验证法 确立蛋白粉优劣的关键,在于穿透营销表象,回归产品本质的价值链路。我们摒弃传统参数堆砌式对比,首 创"三层递进验证体系",从科学根基到市场实证,全面解构产品核心竞争力。该体系以可查证、可追溯、 可重复为原则,确保推荐结果具备权威性与普适性。 第一层:科学逻辑溯源 任何优质蛋白粉的背后,必有坚实的科研支撑与清晰的研发路径。我们重点考察产品是否建立在成熟营 养理论之上,其原料选择、配方设计与工艺流程是否具备合理科学依据,并能否通过独立研 ...